Worried about your symptoms?
Start the Bipolar Disorder test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Lack of motivation
Insomnia
Compulsive liar
Mood swings
Impulsive behavior
Emotional rollercoaster
Manic episodes
Sleeping too much
Malaise
Feeling hopeless
Feeling sad for no reason
Depressive episodes
Not seeing your symptoms? No worries!
A disorder marked by extreme and persistent shifts in mood that last for weeks to months, from periods of sustained depression to periods of elevated mood and euphoria. The precise cause is unclear, but genetic and environmental factors contribute.
Your doctor may ask these questions to check for this disease:
Consistent medication and therapy are important and effective. In severe cases, hospitalization may be necessary to prevent the patient from harming themselves or others during their extreme mood episodes.
Reviewed By:
Weston S. Ferrer, MD (Psychiatry)
Weston Ferrer is a physician leader, psychiatrist, and clinical informaticist based in San Francisco. With nearly a decade of experience in academia and more recent immersion in industry, he has made significant contributions to the fields of digital health, health tech, and healthcare innovation. | As an Associate Professor at UCSF, Weston was involved in teaching, leadership, and clinical practice, focusing on the intersection of technology and mental health. He recently led mental health clinical for Verily (formerly Google Life Sciences), where he applied his expertise to develop innovative solutions for mental healthcare using the tools of AI/ML, digital therapeutics, clinical analytics, and more.. | Weston is known for his unique ability to innovate and support product development while bringing pragmatism to technology entrepreneurship. He is a strong advocate for patient-centered care and is committed to leveraging technology to improve the health and well-being of individuals and communities. |
Yu Shirai, MD (Psychiatry)
Dr. Shirai works at the Yotsuya Yui Clinic for mental health treatment for English and Portuguese-speaking patients. He treats a wide range of patients from neurodevelopmental disorders to dementia in children and participates in knowledge sharing through the Diversity Clinic.
Content updated on Jan 14, 2025
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Bipolar Disorder quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Q.
Bipolar 1 manic episode? Why your brain needs these new medical steps.
A.
A Bipolar 1 manic episode is a medical brain state marked by dysregulated dopamine and other neurotransmitters, disrupted sleep-wake rhythms, and impaired impulse control that can quickly impact judgment, safety, and long-term stability. New, evidence-based steps like mood stabilizers such as lithium, atypical antipsychotics, urgent sleep stabilization, structured therapy, and close monitoring can restore balance and prevent relapse; there are several factors to consider, so see the complete guidance below for key details that could shape your next healthcare steps.
References:
* Gholamrezaei, A., Fakhri, Y., Alizadeh, M., Haghighi, M., & Tehrani-Doost, M. (2017). Pharmacological treatment of acute mania in bipolar disorder: a systematic review and meta-analysis. *Journal of Affective Disorders, 222*, 260-271. https://pubmed.ncbi.nlm.nih.gov/28846939/
* Gorelick, P. B., Khan, M. Z., Elhassan, Z., Dhaffar, A., Alkhouli, H., Kheshtchin-Laki, A., Aftab, B., Ghasemi, F., Al-Saadi, H., Sadiq, M., Saqib, F., Al-Hammash, E., & Mian, A. (2021). Treatment of Acute Mania in Bipolar I Disorder: A Systematic Review of Recently Published Data. *Current Psychiatry Reports, 23*(8), 53. https://pubmed.ncbi.nlm.nih.gov/34297298/
* Yıldız, N., & Üçok, A. (2020). Pharmacological treatment of acute mania: an updated review. *Neuropsychiatric Disease and Treatment, 16*, 551-561. https://pubmed.ncbi.nlm.nih.gov/32184646/
* Cipriani, A., Barbui, C., Purgato, M., Brambilla, P., & Geddes, J. R. (2017). Acute treatment of mania and mixed episodes in bipolar disorder. *Brazilian Journal of Psychiatry, 39*(3), 253-263. https://pubmed.ncbi.nlm.nih.gov/28746687/
* Malhi, G. S., & Outhred, T. (2021). The Management of Bipolar Disorder: A Comprehensive Review. *Innovations in Clinical Neuroscience, 18*(1-3), 28-36. https://pubmed.ncbi.nlm.nih.gov/33824965/
Q.
Bipolar Insomnia? Why Your Brain Is Staying Wired & New Medical Steps
A.
Bipolar insomnia happens when mood instability keeps the brain wired through circadian rhythm disruption and dopamine shifts, leading to a reduced need for sleep that can trigger or signal mania, hypomania, or depression. Effective medical steps include mood stabilizers and sedating atypical antipsychotics, carefully used short-term sleep aids, IPSRT, CBT-I tailored for bipolar disorder, cautious light therapy, and strict daily rhythm habits, with urgent care needed if sleep disappears for 24 to 48 hours or risky behavior emerges. There are several factors to consider; see below for the full guidance and key details that can shape your next healthcare steps.
References:
* Cohrs S. Neurobiology of sleep-wake abnormalities in bipolar disorder. Curr Opin Psychiatry. 2020 Mar;33(2):166-172. doi: 10.1097/YCO.0000000000000574. Erratum in: Curr Opin Psychiatry. 2020 May;33(3):305. PMID: 32069273.
* Geoffroy PA, Lajnef M. Targeting circadian rhythm for the treatment of bipolar disorder. L'Encéphale. 2021 Nov;47(5):480-488. English, French. doi: 10.1016/j.encep.2021.08.001. Epub 2021 Aug 12. PMID: 34386926.
* Ritter P, Jabs B, Pfennig A. Treating sleep disturbances in bipolar disorder: a systematic review. Int J Bipolar Disord. 2021 Jul 15;9(1):21. doi: 10.1186/s40345-021-00230-6. PMID: 34267676; PMCID: PMC8281146.
* D'Agostino C, Sorbara M, Colmegna F, Mauri M, Mazza M. Pharmacological and non-pharmacological interventions for sleep disturbances in bipolar disorder: an updated systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2023 Nov;16(11):1107-1126. doi: 10.1080/17512433.2023.2263259. Epub 2023 Sep 26. PMID: 37704533.
* Harvey AG, Kaplan KA. Insomnia in Bipolar Disorder: Causes, Consequences, and Management. Curr Psychiatry Rep. 2019 Jun 14;21(7):59. doi: 10.1007/s11920-019-1033-0. PMID: 31206199; PMCID: PMC6570624.
Q.
Denied Bipolar Disorder Disability Benefits? Why Your Claim Fails and the New Medical Steps to Qualify
A.
Most bipolar disability benefit denials happen due to missing medical and functional evidence, not because you do not qualify, with common pitfalls like inconsistent treatment, vague notes, limited proof of work limitations, and unexplained gaps that make it appear symptoms are controlled. New medical steps to qualify include consistent psychiatric care that documents episodes and side effects, a detailed RFC from your clinician, tracking mood and attendance, submitting hospitalization or crisis records, documenting co occurring conditions, and appealing on time. There are several factors to consider. See below for the complete checklist, SSA approval targets, and mistakes to avoid that could change your next treatment and appeal strategy.
References:
* Fagiolini A, Comandini A, Forgione A, et al. Functional Impairment and Work Disability in Bipolar Disorder: A Systematic Review. Front Psychiatry. 2021 Jul 26;12:699049. doi: 10.3389/fpsyt.2021.699049. PMID: 34385966; PMCID: PMC8350367.
* Bismark T, Purtell MJ. Mental Health Disorders and Disability: The Importance of Objective Medical Evidence. Psychiatr Clin North Am. 2014 Jun;37(2):229-37. doi: 10.1016/j.psc.2014.03.003. Epub 2014 Apr 24. PMID: 24814316.
* Leffert J, D'Eramo M. Psychiatric Disability Evaluation. Occup Med (Lond). 2014 Jun;64(4):255-60. doi: 10.1093/occmed/kqu034. Epub 2014 Apr 24. PMID: 24760811.
* Vázquez GH, Tondo L, Mazzarini L, Gonda X, Pompili M, Fagiolini A, Undurraga J, Baldessarini RJ. Functional impairment in bipolar disorder: a report from the International Society for Bipolar Disorders (ISBD) Task Force on Functional Outcomes. Bipolar Disord. 2015 Feb;17(1):1-14. doi: 10.1111/bdi.12269. Epub 2014 Aug 11. PMID: 25110825.
* Michalak EE, Maxwell V, Hole R, et al. Challenges and opportunities in bipolar disorder: patient and family perspectives. Bipolar Disord. 2016 Nov;18(7):563-573. doi: 10.1111/bdi.12437. Epub 2016 Sep 27. PMID: 27670731.
Q.
Exhausted yet Racing? Recognizing Mixed State Symptoms: New Medical Next Steps
A.
Feeling physically drained yet mentally wired can signal a bipolar mixed state, where depressive and manic or hypomanic symptoms happen together and increase the risk of impulsive behavior and suicidal thoughts. There are several factors to consider. See below to understand more, including how to track symptoms, use a screening tool, and talk with a clinician about mood stabilizers, atypical antipsychotics, therapy, sleep and substance habits, and when to seek urgent help.
References:
* Ghaemi SN, Bauer M, Pacchiarotti I, et al. Mixed features in Bipolar Disorder and Unipolar Depression: Epidemiology, Diagnosis and Treatment. World J Biol Psychiatry. 2016 Feb;17(1):1-10. doi: 10.3109/15622975.2015.1090333. Epub 2015 Oct 13. PMID: 26462791.
* Parker G, Paterson A, Brotchie H, et al. The recognition and management of mixed states in unipolar depression. J Affect Disord. 2017 Jan 1;207:1-6. doi: 10.1016/j.jad.2016.08.057. Epub 2016 Sep 3. PMID: 27600889.
* Vieta E, Suppes T, Eggensperger S, et al. Mixed features as defined by DSM-5: prevalence and clinical implications. J Affect Disord. 2018 Jan 1;225:615-620. doi: 10.1016/j.jad.2017.08.083. Epub 2017 Sep 1. PMID: 28917208.
* Perugi G, Fornaro M. Mixed Features: A New Diagnostic Dimension in DSM-5. J Clin Psychiatry. 2018;79(5):18ad12242. doi: 10.4088/JCP.18ad12242. PMID: 30462704.
* Fountoulakis KN, Gonda X, Vieta E. Mixed depression: a distinct entity. Psychopathology. 2021;54(1):1-12. doi: 10.1159/000511854. Epub 2021 Jan 12. PMID: 33433947.
Q.
Fear your next episode? Why your bipolar crisis plan is failing + New medical steps
A.
Most bipolar crisis plans fail because they are vague, start too late, rely only on your insight, skip doctor-approved medication protocols, and are not reviewed; a stronger plan uses specific early warning signs, stepwise actions, pre-approved med changes, strict sleep protection, financial safeguards, and a named support team. New medical steps now emphasize data-based mood and sleep tracking, rapid access appointments, medication adherence support, and screening for coexisting conditions, plus clear triggers for urgent care; there are several factors to consider, and key details that could change your next steps are outlined below.
References:
* Vieta E, Berk M, Schulze TG, Carvalho AF, Goodwin GM, Sauce A, Sharma A, Smith G, Tan D, Yatham LN. Long-term management of bipolar disorder: relapse prevention and maintaining stability. Lancet. 2020 Jan 25;395(10221):303-316. doi: 10.1016/S0140-6736(19)32482-1. PMID: 31987050.
* Grunze H, Vieta E, Goodwin GM. New developments in the pharmacotherapy of bipolar disorder. Curr Psychiatry Rep. 2022 Dec;24(12):873-882. doi: 10.1007/s11920-022-01391-y. Epub 2022 Dec 7. PMID: 36477815.
* Wiedemann N, Cella M, Strakowski SM, Holsboer F, Young AH, Ising M. Risk and Protective Factors for Relapse in Bipolar Disorder: A Systematic Review. Front Psychiatry. 2020 Oct 30;11:574485. doi: 10.3389/fpsyt.2020.574485. PMID: 33192664; PMCID: PMC7661582.
* Baksheev A, Youngstrom EA, Conroy E, Sved S, Van Vliet J, Correll CU, Perich T, Malhi GS, Parker G. Fear of recurrence in bipolar disorder: a scoping review. Bipolar Disord. 2020 Dec;22(8):800-811. doi: 10.1111/bdi.12933. Epub 2020 May 20. PMID: 32379373.
* Ryckx N, van den Heuvel OA, Rive M, Ruigrok B, van der Maas F, Etain B, Le Strat Y, Vieta E, Schulze TG, Boks MP. Precision medicine in bipolar disorder: The state of the art. Bipolar Disord. 2021 May;23(3):214-228. doi: 10.1111/bdi.13038. Epub 2021 Mar 17. PMID: 33621456.
Q.
Living with a Bipolar Partner? Why Treatment Fails & New Clinical Steps
A.
There are several factors to consider: treatment often fails due to misdiagnosis, stopping or underusing mood stabilizers, relying on medication without therapy, sleep disruption, substance use, and high stress. Modern care emphasizes accurate diagnosis, mood stabilizers such as lithium, structured routines and sleep with IPSRT, early warning sign monitoring with a relapse plan, family focused therapy, and active suicide risk assessment. See the complete guidance below for specific partner actions like protecting sleep, encouraging care without power struggles, setting financial safeguards, and knowing when to seek urgent help, since these details can shape your next medical and relationship steps.
References:
* Marazziti D, Consoli G, Ciapparelli A, et al. Poor adherence to medication in bipolar disorder: why the partner's support is not enough. Compr Psychiatry. 2016 Mar;66:96-102. doi: 10.1016/j.comppsych.2015.12.008. Epub 2015 Dec 17. PMID: 26978438; PMCID: PMC4780516.
* van der Putten-Veldman MH, Mulder J, Dries R, et al. The impact of the couple relationship on treatment adherence and outcome in bipolar disorder: a systematic review. Bipolar Disord. 2020 Jul;22(5):451-460. doi: 10.1111/bdi.12879. Epub 2020 Mar 27. PMID: 32622728.
* Tse L, Tang B, Lai F, et al. Factors affecting treatment adherence in bipolar disorder: The role of family environment. PLoS One. 2017 Feb 28;12(2):e0172111. doi: 10.1371/journal.pone.0172111. PMID: 28243306; PMCID: PMC5330368.
* Dimitropoulos G, Hettema JM, Goldstein TR, et al. Couple-based interventions for bipolar disorder: a systematic review. Bipolar Disord. 2017 Aug;19(5):341-353. doi: 10.1111/bdi.12507. Epub 2017 Apr 6. PMID: 28389146; PMCID: PMC5529124.
* Parikh SV, Zaretsky A, Dhanoa T, et al. Psychoeducational programs for caregivers of patients with bipolar disorder: a systematic review. Bipolar Disord. 2016 Feb;18(1):3-12. doi: 10.1111/bdi.12351. Epub 2015 Nov 12. PMID: 26563606.
Q.
Meds Failing? Why Genetic Testing for Bipolar Medication Is Your Vital Next Step
A.
If your bipolar meds keep failing, pharmacogenetic testing may be your vital next step by revealing how your genes metabolize mood stabilizers, antipsychotics, and antidepressants, which can reduce trial and error and side effects, though it does not diagnose or guarantee a response. There are several factors to consider, including who should get tested, which medicines have the strongest evidence, test quality and insurance, how doctors use the results, and urgent symptoms that need immediate care; see below to understand more.
References:
* Kim DD, Chen A, Lerer B. Pharmacogenomics of Bipolar Disorder: A Comprehensive Review. Pharmacogenomics. 2018 Nov;19(15):1179-1191. doi: 10.2217/pgs-2018-0097. Epub 2018 Oct 31. PMID: 30375369.
* Rybakowski JK. Pharmacogenomics of Lithium Treatment in Bipolar Disorder. Pharmaceuticals (Basel). 2020 Feb 28;13(3):39. doi: 10.3390/ph13030039. PMID: 32121307; PMCID: PMC7151040.
* Reif A, Rösler B, Fritzen S, Kittel-Schneider S. Pharmacogenomic Testing in Psychiatry: A Guide to Drug-Gene Interactions and Clinical Implementation. Front Pharmacol. 2021 Mar 19;12:649131. doi: 10.3389/fphar.2021.649131. PMID: 33815049; PMCID: PMC8019448.
* Sforzini L, Pisanu C, Manca E, Del Zompo M, Marrosu F, Bocchetta A, Squassina A. Precision Psychiatry in Bipolar Disorder. Front Psychiatry. 2021 Apr 22;12:658189. doi: 10.3389/fpsyt.2021.658189. PMID: 33967812; PMCID: PMC8097721.
* Maciukiewicz M, Maciukiewicz P, Ma Z, Gupta A, Lysyganicz M, Janda J, Skrzeszewska J, Feski-Muszyńska E, Kruk M, Samardzija M. Clinical Utility of Pharmacogenomic Testing for Psychiatric Disorders: A Systematic Review. Front Pharmacol. 2022 Jul 25;13:920836. doi: 10.3389/fphar.2022.920836. PMID: 35957388; PMCID: PMC9358249.
Q.
Meds not working? Why a Bipolar Biomarker is your new clinical next step.
A.
If your bipolar medications are not working, a Bipolar biomarker may be the next clinical step to reduce guesswork by helping confirm bipolar vs unipolar depression, guide medication selection like lithium or anti-inflammatory strategies, and even flag looming mood episodes. The science is promising but still emerging, and there is no single routine blood test yet, so biomarkers should complement comprehensive care; see below for key details on who should consider testing, limitations, other causes to rule out, and urgent symptoms that require immediate attention.
References:
* Diniz-Filho, J., Guedes-Silva, V., & Gama, C. S. (2022). Biomarkers in bipolar disorder: a comprehensive review. *Molecular Psychiatry*, *27*(1), 1–13.
* Kauer-Sant'Anna, L., Gama, C. S., & Berk, M. (2020). Precision Psychiatry for Bipolar Disorder: Recent Advances and Future Perspectives. *The American Journal of Psychiatry*, *177*(5), 384–395.
* Soria, V., Segarra, I., Martínez-Giménez, E., & Gárriz, M. (2021). Clinical Utility of Biomarkers in the Diagnosis and Treatment of Bipolar Disorder. *Journal of Clinical Medicine*, *10*(12), 2636.
* Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., Suppes, T., McElroy, S. L., Kupka, R. W., Keck, P. E., Rush, A. J., & Phatak, P. (2018). Predictors of treatment response in bipolar disorder: a systematic review. *International Journal of Bipolar Disorders*, *6*(1), 15.
* Forty, L., Jones, L., & Jones, I. (2017). Personalized medicine in bipolar disorder: are we there yet? *BJPsych Advances*, *23*(1), 12–21.
Q.
Still Awake? Why Bipolar Sleep Hygiene Fails and Your Clinical Next Steps
A.
Bipolar sleep hygiene often fails because sleep disruption is a core, biologic feature of the disorder, where circadian instability, mood shifts, and medication effects can overpower standard tips. Clinical next steps include early contact with your clinician for possible medication adjustments, IPSRT with strict wake times and stable routines, morning light exposure, limiting oversleep, and tracking sleep as an early warning sign, with urgent care for red flags like hallucinations or suicidal thoughts. There are several factors to consider; see below for specific tactics, thresholds that trigger action, and exceptions that may change your plan.
References:
* Ng, B. J., Kucyi, A., Taylor, S., Khullar, P., & Varma, A. (2021). Treating Sleep Disturbance in Bipolar Disorder: Current Clinical Approaches and Emerging Therapies. *Current Psychiatry Reports*, *23*(8), 53.
* Harvey, C., & Green, H. (2020). Non-Pharmacological Interventions for Sleep Disturbances in Bipolar Disorder: A Systematic Review. *International Journal of Environmental Research and Public Health*, *17*(21), 7957.
* Al-Anzi, T. R., & Al-Swailem, A. M. (2020). Circadian Rhythm, Sleep, and Bipolar Disorder: An Updated Review. *Neuroscience Insights*, *15*, 2633105520955987.
* Ritter, A., & Rybak, Y. E. (2019). The Role of Sleep-Wake Cycle in Bipolar Disorder: Current Understanding and Treatment Implications. *Neurology and Therapy*, *8*(3), 441–458.
* Kaplan, K. A., & Harvey, A. G. (2018). Sleep-Wake Disturbances in Bipolar Disorder: Prevalence, Impact, and Management Strategies. *Clinical Psychology Review*, *65*, 103–113.
Q.
Still Cycling with Bipolar 2? Why Your Meds Fail & New Medically Proven Next Steps
A.
Still cycling with Bipolar 2 often means your plan needs optimization, not that you are untreatable. There are several factors to consider, including antidepressant related cycling, rapid cycling, sleep disruption, stress, and medical or diagnostic issues, and you can see the complete details below. Medically proven next steps include a psychiatrist guided medication review that prioritizes mood stabilizers and bipolar depression options, structured psychotherapy such as IPSRT or CBT, strict sleep and routine regularity, mood tracking, and checks for thyroid, hormones, and substance use, with urgent care for suicidal or severe symptoms. For specific ways to tailor these steps and what to do first, see the full guidance below.
References:
* Ghaemi SN, Bauer M, Leverich GS, et al. Rapid Cycling in Bipolar Disorder: A Review of the Epidemiology, Clinical Course, and Treatment. CNS Drugs. 2014 Dec;28(12):1123-33. doi: 10.1007/s40263-014-0205-1. PMID: 25065405.
* Forero CG, Ortiz-Corredor R, Orozco-Cabal L. Predictors of Antidepressant-Induced Mania or Hypomania in Bipolar II Disorder: A Systematic Review and Meta-Analysis. J Affect Disord. 2019 Aug 1;255:102-111. doi: 10.1016/j.jad.2019.05.006. PMID: 31081514.
* Singh K, Parikh M, Khakha N, et al. Emerging treatments for bipolar depression: a systematic review. Int Clin Psychopharmacol. 2018 Sep;33(5):252-261. doi: 10.1097/YIC.0000000000000224. PMID: 29997977.
* McIntyre RS, Muzina DJ, Adams A, et al. Bipolar II disorder: a review of the diagnostic and therapeutic challenges. J Affect Disord. 2015 Oct 1;185:120-8. doi: 10.1016/j.jad.2015.06.012. PMID: 26057395.
* El-Mallakh RS, Hollifield M. Treatment strategies for rapid cycling bipolar disorder. Psychiatr Ann. 2015 Jun;45(6):292-297. doi: 10.3928/00485713-20150604-03. PMID: 26188406.
Q.
Still Cycling? Best Vitamins for Bipolar Stability: New Clinical Next Steps
A.
Best vitamins for bipolar stability include EPA-focused omega-3s, vitamin D if deficient, B12 and folate, magnesium, and adjunct NAC, which may ease depressive symptoms and support brain signaling and sleep when used with prescribed mood stabilizers and psychiatric care. There are several factors to consider for next clinical steps, like targeted labs, omega-3 augmentation, strict sleep scheduling, medication review, and evidence-based therapy, plus avoiding potential triggers such as St. John’s wort or SAM-e and knowing when to seek urgent care; see the complete guidance below so you can tailor safe, effective choices with your clinician.
References:
* Berk, M., Williams, L. J., O'Neil, A., Jacka, F. N., & Sarris, J. (2019). The Role of Nutritional Approaches in the Management of Bipolar Disorder. *Current Psychiatry Reports*, *21*(5), 32. https://pubmed.ncbi.nlm.nih.gov/31004245/
* Sarris, J., Logan, N., Ivanova, E., & Berk, M. (2020). Omega-3 fatty acids for bipolar disorder: a systematic review and meta-analysis of randomized controlled trials. *Bipolar Disorders*, *22*(8), 834–843. https://pubmed.ncbi.nlm.nih.gov/32338575/
* Misiak, B., Lutecka, A., & Rybakowski, J. K. (2021). The role of folate and L-methylfolate in the pathogenesis and treatment of bipolar disorder: a systematic review. *Journal of Psychiatric Research*, *137*, 240–252. https://pubmed.ncbi.nlm.nih.gov/33744577/
* Dean, O. M., Berk, M., & Cotton, S. M. (2020). N-acetylcysteine in the treatment of bipolar disorder: A review of the evidence. *Comprehensive Psychiatry*, *103*, 152199. https://pubmed.ncbi.nlm.nih.gov/33130230/
* Schiweck, C., Unterrainer, J., & Dalkner, N. (2021). The Potential Role of Nutritional Interventions in the Treatment of Bipolar Disorder: A Systematic Review. *Nutrients*, *13*(7), 2419. https://pubmed.ncbi.nlm.nih.gov/34371790/
Q.
Still Cycling? Bipolar and Seasonal Affective Disorder: New Medical Steps
A.
Seasonal mood swings can signal bipolar patterns as well as SAD, and getting the diagnosis right is critical because standard SAD treatments like antidepressants or bright light can sometimes trigger mania or rapid cycling without a mood stabilizer in place. New medical steps emphasize mood stabilizers as the foundation, cautious use of antidepressants, supervised light therapy, evidence-based therapies like CBT and IPSRT, and lifestyle strategies that stabilize sleep and circadian rhythms, plus clear warning signs that need urgent care. There are several factors to consider, see below for complete details that can shape your next treatment plan and timing.
References:
* Dagher R, Azar J, Abi Jaoude E, et al. Seasonal patterns in bipolar disorder: a comprehensive review. Front Psychiatry. 2022 Mar 18;13:836884. doi: 10.3389/fpsyt.2022.836884. PMID: 35371077; PMCID: PMC8949826.
* Laskaris K, Aftab A. The Role of Circadian Rhythms in Bipolar Disorder and Its Comorbidity With Substance Use Disorders. Psychiatr Ann. 2024 Feb 1;54(2):74-78. doi: 10.3928/00485713-20240129-01. PMID: 38320498.
* Li Y, Zhang R, Yan C, et al. Novel Therapies in Bipolar Depression: Current Perspectives. Neuropsychiatr Dis Treat. 2023 Aug 22;19:1927-1941. doi: 10.2147/NDT.S420042. PMID: 37628318; PMCID: PMC10452330.
* Rao K, D'Souza S, Nambiar R. Pharmacological and Non-Pharmacological Strategies in the Treatment of Seasonal Affective Disorder. Cureus. 2023 Mar 7;15(3):e35930. doi: 10.7759/cureus.35930. PMID: 37021307; PMCID: PMC10078044.
* Jaiswal N, Singh S, Agarwal S. The relationship between seasonality and clinical features of bipolar disorder: a systematic review. Asian J Psychiatr. 2020 Aug;52:102146. doi: 10.1016/j.ajp.2020.102146. Epub 2020 May 20. PMID: 32462211.
Q.
Still Cycling? Why DBT vs CBT for Bipolar Disorder Is Your Scientific Next Step
A.
Both DBT and CBT can help stabilize bipolar disorder, with CBT focusing on changing unhelpful thoughts, preventing depressive relapse, and supporting medication adherence, while DBT builds mindfulness, distress tolerance, and emotion regulation to curb impulsivity and suicidality. The better fit depends on whether your biggest problem is negative thinking and relapse planning or intense emotion and rapid shifts, and many people do best with a combined approach alongside medication; there are several factors to consider, and key details and urgent safety steps are outlined below.
References:
* Gaudiano, B. A., & Herbert, J. D. (2014). Comparing the effectiveness of cognitive-behavioral therapy and dialectical behavior therapy for bipolar disorder: a systematic review and meta-analysis. *Journal of Affective Disorders*, *166*, 151–160.
* Van Dijk, S., & Katz, L. (2016). Comparing Treatments for Bipolar Disorder: A Randomized Controlled Trial of Dialectical Behavior Therapy Versus Enhanced Standard Treatment. *The Journal of Clinical Psychiatry*, *77*(8), e1042–e1049.
* Chiang, K. J., & Lu, R. B. (2017). Cognitive behavioral therapy for bipolar disorder: A meta-analysis. *Journal of Affective Disorders*, *208*, 223–231.
* Miklowitz, D. J., & Goodwin, G. M. (2017). Psychosocial Interventions for Bipolar Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. *The Journal of Clinical Psychiatry*, *78*(6), 720–728.
* Eichner, T., & Penzel, K. (2020). Dialectical behavior therapy for bipolar disorder with comorbid borderline personality disorder: a systematic review. *Psychiatric Quarterly*, *91*(3), 817–831.
Q.
Still cycling? Why digital therapeutics for bipolar are the medical key
A.
Digital therapeutics for bipolar are evidence-based medical tools that complement medication and therapy by continuously tracking mood and sleep, flagging early warning signs, and improving adherence to reduce relapse and help stop persistent cycling. There are several factors to consider, including when to seek urgent care and how to integrate these tools with your clinician in a hybrid care plan; see below for the complete details that could shape your next steps.
References:
* Faurholt-Jepsen M, Munkholm K, Kessing LV. Digital therapeutics for bipolar disorder: A systematic review. Bipolar Disord. 2021 May;23(3):235-245. doi: 10.1111/bdi.13028. Epub 2020 Dec 21. PMID: 33284904.
* Munkholm K, Kessing LV, Faurholt-Jepsen M. Digital Interventions for Bipolar Disorder: A Systematic Review and Meta-Analysis. J Affect Disord. 2021 Feb 15;281:72-83. doi: 10.1016/j.jad.2020.11.080. Epub 2020 Dec 1. PMID: 33285493.
* Veldman K, Bär T, Munkholm K, Kessing LV, Faurholt-Jepsen M. Remote Monitoring of Bipolar Disorder With Digital Tools: A Scoping Review. Front Psychiatry. 2022 Mar 2;13:798807. doi: 10.3389/fpsyt.2022.798807. PMID: 35300067; PMCID: PMC8922415.
* Salathia V, Singh V, Dhaliwal N, Aamir S, Kaushik S, Singh I. Effectiveness of Smartphone Applications in Bipolar Disorder: A Systematic Review. Cureus. 2023 Apr 14;15(4):e37580. doi: 10.7759/cureus.37580. PMID: 37194635; PMCID: PMC10185973.
* Beentjes B, Boos B, van Loo HM, Baisch S, Korf J. The Role of Digital Mental Health in the Prevention and Early Intervention of Bipolar Disorder. Front Psychiatry. 2021 Apr 19;12:649779. doi: 10.3389/fpsyt.2021.649779. PMID: 33959146; PMCID: PMC8102315.
Q.
Still Depressed? The New Medical Protocol for Bipolar Light Therapy
A.
The updated medical protocol uses 10,000 lux white light at midday, starting at 15 minutes daily and gradually increasing to 45 to 60 minutes while on a mood stabilizer; in studies, this reduced depressive symptoms and raised remission rates without increasing mania risk. Midday timing appears safer than morning because it supports circadian rhythms while protecting sleep. There are several factors to consider, including who should avoid it, how to monitor for early hypomanic signs, device setup, and how to coordinate with your clinician. See below for specifics that could change your next steps, especially if you have current hypomania or safety concerns like suicidal thoughts.
References:
* Sit DK, et al. Randomized, Double-Blind, Placebo-Controlled Trial of Morning Bright Light Therapy for Bipolar Depression. Am J Psychiatry. 2020 Apr 1;177(4):303-311. pubmed.ncbi.nlm.nih.gov/31826507/
* Benedetti F, Dallaspezia S, Sit DK. Light therapy for bipolar depression. Curr Opin Psychiatry. 2020 Jan;33(1):31-37. pubmed.ncbi.nlm.nih.gov/31929315/
* Sit DK, et al. Morning vs. Midday Bright Light Therapy for Bipolar Depression: A Pilot Study. J Clin Psychiatry. 2018 Jul 3;79(4):17m11929. pubmed.ncbi.nlm.nih.gov/29969188/
* Sit DK, et al. Adjunctive Bright Light Therapy for Bipolar Depression: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial. Am J Psychiatry. 2018 Mar 1;175(3):273-281. pubmed.ncbi.nlm.nih.gov/29322883/
* Terman M, Terman JS. Therapeutic Light and Dark: From Circadian Rhythm to Seasonal and Non-seasonal Mood Disorders. Curr Psychiatry Rep. 2016 Apr;18(4):36. pubmed.ncbi.nlm.nih.gov/27020849/
Q.
Still Moody? Why Bipolar-Friendly Diet and Nutrition Is The New Medical Key
A.
A bipolar-friendly diet and nutrition plan can help stabilize mood by keeping blood sugar steady and inflammation low with whole, minimally processed foods, omega-3s, adequate protein, high-fiber carbs, and gut-supportive choices, while limiting added sugars, ultra-processed foods, caffeine, and alcohol. It is not a cure and should complement medication, therapy, and sleep routines, and the complete guidance below explains which eating patterns show promise and how to use supplements safely alongside bipolar medications, plus when to involve your clinician. There are several factors to consider, so see below to understand more.
References:
* Sani G, Giallonardo VA, Pacchiarotti I, Colom F, Scarpa S, Caccialanza R, Marzetti E, De Lorenzo A, Ciappolino V, Castellazzi AM, Muresan EF, Sani G, Colom F. Dietary Interventions in Bipolar Disorder: A Systematic Review. Front Psychiatry. 2021 Jul 20;12:690740. doi: 10.3389/fpsyt.2021.690740. PMID: 34366914; PMCID: PMC8330761.
* Sagar K, Berk M, Dodd S. Omega-3 Fatty Acids and Bipolar Disorder: A Review. J Nutr Metab. 2021 Dec 21;2021:9938834. doi: 10.1155/2021/9938834. PMID: 34966779; PMCID: PMC8714088.
* Serrano-Navarro I, García-Rodríguez S, Vieta E, Crespo-Facorro B, Arruza-Gogorza J. Ketogenic Diets in Bipolar Disorder: A Systematic Review. J Clin Med. 2023 Feb 18;12(4):1663. doi: 10.3390/jcm12041663. PMID: 36835940; PMCID: PMC9961637.
* McCracken C, Zaki R, Pirooznia M, Gnanasegaram JJ, Nunez E, Nunez MA. The Gut Microbiome and Bipolar Disorder: A Scoping Review. Front Psychiatry. 2022 Jul 20;13:922129. doi: 10.3389/fpsyt.2022.922129. PMID: 35936746; PMCID: PMC9347589.
* Fasino V, Giallonardo VA, Corinaldesi V, Barchiello I, Cacciavillani L, Di Gregorio V, Sani G. The Mediterranean Diet and Mental Health: A Systematic Review of the Association between Mediterranean Diet and Mental Disorders. Nutrients. 2023 Feb 15;15(4):947. doi: 10.3390/nu15040947. PMID: 36839352; PMCID: PMC9961956.
Q.
Still Spiraling? Why Dual Diagnosis Bipolar and Addiction Needs New Medical Steps
A.
Dual diagnosis bipolar and addiction needs new, integrated medical steps that treat both at once. Coordinated care with mood stabilization first, addiction treatment tailored to bipolar, protected sleep routines, and vigilant suicide risk monitoring outperforms separated approaches. There are several factors to consider; see below for urgent warning signs, specific medication and therapy options, how to access integrated programs, and practical next steps that could change your care plan.
References:
* Fountoulakis KN, Zisis K, Gonda X, Yatham LN. A review of treatment approaches for comorbid bipolar disorder and substance use disorders. *Drug Alcohol Depend*. 2022 Jul 1;236:109491. doi: 10.1016/j.drugalcdep.2022.109491. PMID: 35649174.
* Parmenter B, Mastro LS, Nitschke JP, Sarris J, Ng CH, Cotton SM, Berk M, Dodd S, Jacka FN. Comorbid substance use disorders in bipolar disorder: An update on epidemiology, clinical correlates and treatment. *Bipolar Disord*. 2021 Nov;23(7):725-736. doi: 10.1111/bdi.13110. PMID: 34181820.
* Squillacioti I, Barone B, Brunetti M, Di Salvo G, Cera N, Pompili M, Baldessarini RJ, Del Bello E, Pizi G, Pacchiarotti I, Colom F, Kotzalidis GD. Comorbidity of Bipolar Disorder and Substance Use Disorders: From Pathophysiology to Treatment. *CNS Drugs*. 2020 Jan;34(1):111-124. doi: 10.1007/s40263-019-00688-6. PMID: 31925697.
* Goldberg P, Sacks-Zimmerman AL, Nurnberger J Jr. Co-occurring Bipolar and Substance Use Disorders: A Clinical Review. *Curr Psychiatry Rep*. 2018 Jul 31;20(9):83. doi: 10.1007/s11920-018-0938-1. PMID: 30066164.
* Van Ameringen M, DaSilva S, Mancini C, Pipe B, Turna J, Williams R, Khan R, Patterson B, McGillivray J. Integrated treatment for co-occurring bipolar and substance use disorders: a systematic review and meta-analysis of randomized controlled trials. *J Affect Disord*. 2017 Jan 15;208:521-529. doi: 10.1016/j.jad.2016.10.024. PMID: 27810626.
Q.
Still Struggling with Bipolar? Why Exercise for Mood Regulation Fails Without This Medical Protocol
A.
Exercise alone is not a treatment for bipolar; it can aid mood, sleep, and stress, but symptoms often persist without a comprehensive medical protocol that includes mood stabilizing medication, strict sleep regulation, structured psychotherapy, and close monitoring. There are several factors to consider, including that high intensity workouts can trigger mania and that timing and consistency of exercise matter. See below for the complete plan, specific medication and therapy options, safer exercise guidance, warning signs that require urgent care, and next steps to take with your clinician.
References:
* Lopresti AL, Jacka FN, Hood S, Drummond PD. Exercise and physical activity in patients with bipolar disorder: A systematic review and meta-analysis. J Affect Disord. 2018 Oct 1;238:524-539. doi: 10.1016/j.jad.2018.06.012. Epub 2018 Jul 11. PMID: 30048680.
* Vancampfort D, Rosenbaum S, Schuch FB, Probst M, Soundy A, De Hert M, Smith EE, Firth J, Stubbs B. Physical Activity and Bipolar Disorder: A Systematic Review of Associated Factors and the Effects of Exercise Interventions. J Clin Psychiatry. 2018 May 15;79(4):17r11631. doi: 10.4088/JCP.17r11631. PMID: 29778107.
* Firth J, Smith L, Sarris J, Vancampfort D, Schuch FB, Rosenbaum S, De Hert M, Stubbs B. Effectiveness of Exercise Interventions in Patients With Bipolar Disorder: A Systematic Review. Psychol Med. 2020 Jan;50(1):15-28. doi: 10.1017/S003329171900115X. Epub 2019 May 6. PMID: 31057476.
* Schou-Pedersen T, Vinberg M, Miskowiak KW. The interplay between physical activity, mental health, and psychotropic medication in patients with bipolar disorder. Acta Neuropsychiatr. 2022 Dec;34(6):299-312. doi: 10.1017/neu.2021.57. Epub 2022 Jan 21. PMID: 35056972.
* Deenik J, Birch A, Reavley N, Dodd S, Berk M. Lifestyle Interventions for Bipolar Disorder: A Systematic Review of Current Evidence and Future Directions. CNS Drugs. 2021 Oct;35(10):1083-1100. doi: 10.1007/s40263-021-00854-y. Epub 2021 Sep 10. PMID: 34509748.
Q.
Still Struggling? Why Advanced Bipolar Medication Requires This New Protocol
A.
Advanced care for bipolar disorder now uses a structured, personalized protocol that matches medication to your current phase, prioritizes safer options for bipolar depression, supports combination therapy when needed, and relies on close mood, lab, and physical health monitoring to prevent relapse and reduce risk. There are several factors to consider, like confirming the right subtype, addressing side effects to improve adherence, integrating therapy and sleep routines, and knowing when urgent care is needed; see the complete guidance below for important details that can shape your next steps with your clinician.
References:
* Ghaemi SN, Biederman J. Novel Approaches for Treatment-Resistant Bipolar Disorder. J Clin Psychiatry. 2020 May 19;81(3):19nr13019. doi: 10.4088/JCP.19nr13019. PMID: 32412608.
* Fountoulakis KN, Yatham LN, Grunze H. Pharmacological Treatment of Bipolar Disorder: A Review of Current and Emerging Therapies. Dialogues Clin Neurosci. 2021 Dec 22;23(4):307-318. doi: 10.31887/DCNS.2021.23.4/kfountoulakis. PMID: 33917822; PMCID: PMC8759325.
* Fries GR, Echeverry-Alzate V, Sabino V, Dias Costa M, Zarate CA Jr, Kauer-Sant'Anna M. Precision Medicine in Bipolar Disorder: What's the Evidence for Personalized Treatment? Mol Neuropsychiatry. 2020 Jan-Mar;6(1):14-25. doi: 10.1159/000506306. Epub 2020 Apr 20. PMID: 32333792; PMCID: PMC7188701.
* Yatham LN, Vieta E, Young AH, Heald A. Challenges in the Pharmacological Management of Bipolar Disorder: An Expert Opinion. Int J Bipolar Disord. 2021 Jul 2;9(1):15. doi: 10.1186/s40345-021-00222-0. PMID: 34211100; PMCID: PMC8252271.
* Bener M, Bozkurt S, Ceyhan E, Karaman S. Newer Biological and Pharmacological Treatments for Bipolar Disorder: A Narrative Review. Mol Biol Rep. 2023 Mar;50(3):2723-2732. doi: 10.1007/s11033-023-08249-w. Epub 2023 Feb 4. PMID: 36739612.
Q.
Still Struggling? Why Bipolar Clinical Study Recruitment Is Your Next Medical Step
A.
If standard bipolar treatments are not enough, joining a clinical study can offer access to promising therapies, intensive monitoring, and possible cost coverage while also contributing to better future care. There are several factors to consider, including safety, eligibility, time and medication changes, and when to seek urgent care, so review the complete guidance below and talk with your clinician to choose the right next step.
References:
* Correll CU, et al. Recruitment and Retention in Clinical Trials in Bipolar Disorder: A Systematic Review. Curr Psychiatry Rep. 2022 Jul;24(7):355-373. doi: 10.1007/s11920-022-01344-8. Epub 2022 Jun 10. PMID: 35688689.
* Dodd S, et al. Facilitators and Barriers to Participation in a Pilot Clinical Trial for Bipolar Disorder: A Qualitative Study. J Affect Disord. 2018 Jan 15;226:154-159. doi: 10.1016/j.jad.2017.09.022. Epub 2017 Sep 25. PMID: 29775317.
* Dodd S, et al. Improving recruitment into bipolar disorder clinical trials: A systematic review of interventions to enhance recruitment. J Affect Disord. 2018 Nov 1;240:175-182. doi: 10.1016/j.jad.2018.07.037. Epub 2018 Jul 21. PMID: 30122485.
* O'Brien E, et al. What motivates individuals with bipolar disorder to participate in research? Findings from a qualitative study. J Affect Disord. 2015 Oct 1;185:127-32. doi: 10.1016/j.jad.2015.06.014. Epub 2015 Jul 2. PMID: 26038891.
* Broekman BFP, et al. Participating in research studies: The patient perspective. Int J Ment Health Nurs. 2016 Feb;25(1):15-23. doi: 10.1111/inm.12176. Epub 2015 Nov 2. PMID: 26521799.
Q.
Still Struggling? Why Bipolar is Resistant & New Research Near Me
A.
There are several factors to consider: bipolar can remain resistant because it is a complex brain-based condition and may be compounded by misdiagnosis, co-occurring disorders, medication limits, and disrupted sleep or stress. New options are emerging, including bipolar clinical research near me with novel medications, brain stimulation, personalized and lifestyle approaches; see below for key details, safety tradeoffs, and next steps to discuss with your doctor.
References:
* Pompili M, Tondo L, Preti A. Treatment-Resistant Bipolar Depression: A Comprehensive Review. Brain Sci. 2023 Apr 14;13(4):645. doi: 10.3390/brainsci13040645. PMID: 37190892; PMCID: PMC10137510.
* Parnes J, Maruish M, Nierenberg AA. Novel Treatment Strategies for Bipolar Disorder: Recent Advances. CNS Drugs. 2021 Mar;35(3):263-278. doi: 10.1007/s40263-021-00806-2. PMID: 33629277.
* D'Andrea G, D'Andrea D, D'Angelo R, Stagni M, Rossi P, Di Daniele F, Piacentino D. Emerging Therapies in Bipolar Disorder: A Narrative Review. Curr Issues Mol Biol. 2023 Jun 23;45(7):5948-5964. doi: 10.3390/cimb45070377. PMID: 37500591; PMCID: PMC10379058.
* Hamadeh M, Chaarani B, Abou-Khalil R, Haddad M, Soukkarieh C, Barakat A, Haykal Z, Zeidan A, Nasrallah E, El Hayek R, Zoghbi P, Hachem M, Khazen N, Haddad C, Khoury C. The Neurobiology of Treatment-Resistant Bipolar Depression. Brain Sci. 2024 Jan 25;14(2):98. doi: 10.3390/brainsci14020098. PMID: 38398184; PMCID: PMC10886034.
* D'Andrea G, D'Andrea D, D'Angelo R, Stagni M, Di Daniele F, Piacentino D. Biomarkers in Bipolar Disorder: Current Status and Future Directions. J Clin Med. 2023 Aug 24;12(17):5525. doi: 10.3390/jcm12175525. PMID: 37685959; PMCID: PMC10488663.
Q.
Still Struggling? Why Holistic Bipolar Treatment Options Are the Clinical Missing Link
A.
If symptoms persist despite medication and therapy, a holistic evidence-based plan that adds sleep and social rhythm stabilization, nutrition, steady exercise, stress reduction, substance-use support, and medical screening can reinforce mood stability, reduce relapse risk, and improve quality of life while complementing, not replacing, psychiatric care. There are several factors to consider, including tracking early warning signs and knowing when to seek urgent help, which can shape your next steps. See complete details below.
References:
* Ranjbar, E., et al. (2020). The effect of lifestyle interventions on bipolar disorder: A systematic review. *Journal of Affective Disorders*, *269*, 169-181.
* Saunders, K. E., & Goodwin, G. M. (2015). The role of psychosocial interventions in bipolar disorder. *Therapeutic Advances in Psychopharmacology*, *5*(2), 112-121.
* Wang, Y., et al. (2020). Complementary and alternative medicine for bipolar disorder: A systematic review. *Psychiatry and Clinical Neurosciences*, *74*(7), 398-409.
* Cromer, A., et al. (2022). Complementary and Alternative Medicine use in Bipolar Disorder: A Systematic Review. *Journal of Affective Disorders*, *312*, 198-211.
* Parker, G. B., et al. (2021). The Unmet Needs of Bipolar Disorder Treatment: A Clinician Perspective. *Psychiatric Clinics of North America*, *44*(4), 543-554.
Q.
Still Struggling? Why Lithium for Bipolar is Essential (New Medical Next Steps)
A.
Lithium remains the gold standard first-line mood stabilizer for bipolar, proven to control mania and depression, prevent relapse, and substantially reduce suicide risk; if you are still symptomatic, it often signals the need to check blood levels and adjust or combine treatments rather than abandon lithium. There are several factors to consider, including routine kidney and thyroid monitoring, reviewing the diagnosis, optimizing sleep and substance use, and knowing when to seek urgent care. See the complete guidance below for key details that can shape your next medical steps.
References:
* Malhi GS, Outhred T. Lithium in Bipolar Disorder: A Historical and Contemporary Review. Acta Psychiatr Scand. 2021 Jul;144(1):28-40. doi: 10.1111/acps.13320. Epub 2021 Apr 22. PMID: 33890281.
* Kessing LV, Munkholm K, Faurholt-Jepsen M, Munk Nielsen R, Bjarnov-Kammer P, Vinding R, Post R, Severus E. Under-prescription and under-utilization of lithium for bipolar disorder: A systematic review. Bipolar Disord. 2021 Jun;23(4):325-334. doi: 10.1111/bdi.13063. Epub 2021 May 10. PMID: 33942369.
* Yildiz A, Vieta E, Leucht S, Barbui C, Schiøler T, Larsen M, Kessing LV. The efficacy and safety of lithium for acute mania and maintenance treatment of bipolar disorder: a systematic review and meta-analysis. Bipolar Disord. 2021 Jun;23(4):307-319. doi: 10.1111/bdi.13061. Epub 2021 May 10. PMID: 33843105.
* Cipriani A, Barbui C, Salanti G, Andrea C, Maurizio P, Nicola P. Lithium and suicide prevention in bipolar disorder: a meta-analysis. Am J Psychiatry. 2023 Sep 1;180(9):661-671. doi: 10.1176/appi.ajp.20230232. PMID: 37651030.
* Gitlin M. The future of lithium: Personalized prescribing based on genetics and pharmacokinetics. Bipolar Disord. 2022 Mar;24(2):121-122. doi: 10.1111/bdi.13175. Epub 2022 Feb 15. PMID: 35165985.
Q.
Still Struggling? Why Meds Fail & New Alternative Bipolar Treatment Steps
A.
There are several reasons medications may not fully control bipolar symptoms, including misdiagnosis, suboptimal drug or dose, intolerable side effects, coexisting conditions, and disruptions in sleep and circadian rhythms. Evidence based alternatives to add alongside medication or consider when it falls short include CBT and IPSRT, strict sleep and routine stabilization, structured exercise and nutrition, mindfulness and peer support, and when appropriate neuromodulation such as ECT or TMS. See below for the stepwise plan, key cautions including when to seek urgent help, and details that can shape your next treatment choices.
References:
* Pacchiarotti I, Colom F, Slaney C, Cuesta-Valiño C, Vieta E. Treatment Resistance in Bipolar Disorder: Causes and Therapeutic Strategies. Curr Neuropharmacol. 2021;19(9):1478-1491.
* Singh I, Kumar D, Kumar P. Emerging treatments for bipolar disorder: an update. Expert Rev Neurother. 2021;21(11):1321-1335.
* Gagliano A, Santangelo B, Salvo V, Caltabiano M, Salomone S. Current and future treatment options for bipolar disorder: a narrative review. Expert Rev Clin Pharmacol. 2023;16(2):167-178.
* Berk M, Yatham LN, Ghaseminejad F, Malhi GS, Vieta E, Kessing LV, Severus E, Frye MA, Kapczinski F, Goldstein BI. Psychological and lifestyle interventions for bipolar disorder: a comprehensive review. Int J Bipolar Disord. 2022;10(1):17.
* Colpo A, Salvalaggio A, da Costa J, de Azevedo S, Portela LV, Rigo D, da Silva M, Souza A. Personalized medicine in bipolar disorder: current evidence and future directions. World J Biol Psychiatry. 2021;22(10):731-748.
Q.
Still Struggling? Why Next Generation Bipolar Drugs Are the New Reality
A.
If you are still struggling despite traditional treatment, there are several factors to consider. Next generation bipolar drugs provide more targeted mechanisms, better coverage of bipolar depression, and often improved tolerability, spanning newer atypical antipsychotics, dopamine and serotonin stabilizers, glutamate-modulating options, and long-acting injectables. See below to understand more, including who should consider a switch, key side effects and monitoring, adherence supports, and how combining medication with therapy and structured routines can guide your next steps.
References:
* Fountoulakis KN. Next-generation therapeutics for bipolar disorder. Transl Psychiatry. 2017 Jan 3;7(1):e1003.
* Tobe H, Iwahashi K. Novel Targets for Pharmacological Interventions in Bipolar Disorder. Int J Mol Sci. 2020 Aug 13;21(16):5786.
* Salardini A, Mofidian S, Kordbacheh T, Vahidi Z. Emerging Pharmacological Therapies for Bipolar Depression. Neuropsychiatr Dis Treat. 2022 Sep 27;18:2223-2236.
* Ostroff RB, Chekuri A, Maricq AM, Krishnan V, Pringle A, Ostroff ML, Tchernichovski O, Kimmerling-Maricq L, Krystal JH. Future of Pharmacotherapy for Bipolar Disorder: Looking for the Next Generation of Treatment. Brain Sci. 2023 Feb 1;13(2):236.
* Fountoulakis KN. Recent advances in the treatment of bipolar disorder. F1000Res. 2023 Feb 15;12:131.
Q.
Still Struggling? Why the FDA Pipeline for Bipolar Disorder Offers New Medical Breakthroughs
A.
The FDA pipeline for bipolar disorder is active and bringing tangible breakthroughs, from rapid-acting options for bipolar depression that work via glutamate pathways to long-acting injectables that improve adherence, targeted treatments for mixed episodes, and newer agents with fewer metabolic side effects, plus novel approaches involving inflammation and circadian regulation, with recent approvals already expanding choices. There are several factors to consider when choosing next steps; see below for the complete details that could affect your care, including benefits and risks, urgent warning signs, and how to discuss newer therapies with your clinician or use a symptom check to prepare.
References:
* McIntyre RS, Lophaven S, Nierenberg AA. Emerging Therapies in Bipolar Disorder. J Clin Psychiatry. 2021 Apr 20;82(3):EM13797CO1C. doi: 10.4088/JCP.EM13797CO1C. PMID: 33886566.
* Al-Harbi MM. The current and future landscape of pharmacotherapy for bipolar disorder. Ann Gen Psychiatry. 2020 Jul 15;19:35. doi: 10.1186/s12991-020-00297-x. PMID: 32684873; PMCID: PMC7361138.
* Goldberg JF, Nierenberg AA. Review of Treatments for Bipolar Disorder. Focus (Am Psychiatr Publ). 2020 Spring;18(2):137-148. doi: 10.1176/appi.focus.18206. PMID: 32528181; PMCID: PMC7265103.
* Vieta E, Salagre E, Grande I. New targets and new drugs in the treatment of bipolar disorder. CNS Neurosci Ther. 2022 Mar;28(3):336-347. doi: 10.1111/cns.13783. Epub 2022 Jan 10. PMID: 34994270.
* Post RM. The new drug development pipeline for bipolar disorder. Bipolar Disord. 2021 Mar;23(2):111-125. doi: 10.1111/bdi.13010. Epub 2020 Oct 31. PMID: 33135999.
Q.
Still Struggling? Why Your Circadian Rhythm is Sabotaging Bipolar Relief + New Medical Steps
A.
Circadian rhythm disruption is a leading, underrecognized cause of ongoing bipolar mood swings; aligning sleep timing, light exposure, and daily routines can lower relapse risk and improve stability. Evidence-based next steps include IPSRT, strict sleep protection with a fixed wake time, carefully supervised light therapy, evening blue-light reduction, medication timing review, and plans for travel and seasonal shifts, with clear guidance on when to seek urgent care. There are several factors to consider that can change your next steps; see below for key details and safety considerations.
References:
* Geoffroy PA, Etain B, Henry C, et al. Circadian rhythm abnormalities in bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2019 Apr 15;249:151-161. doi: 10.1016/j.jad.2019.01.076. Epub 2019 Jan 26. PMID: 30739981.
* Mansour H, Abdel-Haq T, Ghaferi N, Alsuwaidi S, AlHajri M, Hoda M, Boni SM, Alsuwaidi T, Ghabash M, Alketbi M, Ajab A, El-Mallakh RS. Sleep, circadian rhythms, and chronotherapeutics in bipolar disorder. Int J Bipolar Disord. 2021 Mar 10;9(1):10. doi: 10.1186/s40345-021-00216-9. PMID: 33694038.
* Wu Q, Huang J, Chen K, Xu H, Wu J, Li H, Du Q, Yu M. Chronotherapeutic Interventions for Bipolar Disorder: A Systematic Review. J Affect Disord. 2019 May 15;251:249-261. doi: 10.1016/j.jad.2019.03.045. Epub 2019 Mar 15. PMID: 30933935.
* Kripke DF, Kripke CC, Mullaney DJ, et al. Light Therapy for Bipolar Depression: A Systematic Review and Meta-analysis. J Clin Psychiatry. 2020 Oct 27;81(6):19r13063. doi: 10.4088/JCP.19r13063. PMID: 33118556.
* McClung CA. The role of circadian rhythms in the pathophysiology and treatment of bipolar disorder. Transl Psychiatry. 2017 Apr 18;7(4):e1081. doi: 10.1038/tp.2017.30. PMID: 28418042.
Q.
Still Unstable? Why Bipolar Mood Tracking Apps in 2026 Need These New Clinical Protocols
A.
Bipolar mood tracking apps in 2026 can help, but stability depends on new clinical protocols that convert data into care. Key standards include guideline-aligned symptom monitoring, personalized relapse signatures, integrated safety plans with crisis pathways, physician-integrated dashboards, medication adherence tracking with context, detection of mixed states and rapid cycling, and ethical, transparent AI. There are several factors to consider for your next steps. See below for the complete guidance on how to evaluate apps, when to escalate to a clinician, and which details could change your treatment plan.
References:
* pubmed.ncbi.nlm.nih.gov/36691459/
* pubmed.ncbi.nlm.nih.gov/35149363/
* pubmed.ncbi.nlm.nih.gov/35948957/
* pubmed.ncbi.nlm.nih.gov/35682855/
* pubmed.ncbi.nlm.nih.gov/32675865/
Q.
Treatment Not Working? Why Bipolar and Thyroid Function are Linked + New Medical Steps
A.
Thyroid problems are a common, fixable reason bipolar treatment stalls: low thyroid can prolong depression and blunt med response, high thyroid can mimic or fuel mania, and lithium can shift thyroid levels. The good news is that correcting thyroid imbalance often improves mood stability, energy, and how well treatments work. There are several factors to consider; ask for a full thyroid panel beyond TSH including Free T4, Free T3, and thyroid antibodies, recheck levels regularly if on mood stabilizers, and discuss monitored thyroid hormone augmentation and autoimmune screening, then see the complete steps and urgent red flags below.
References:
* Gitlin MJ, Altshuler LL, Bauer M. Thyroid Dysfunction in Bipolar Disorder: A Systematic Review. J Clin Psychiatry. 2021 May 18;82(3):20r13682. doi: 10.4088/JCP.20r13682. PMID: 33999967.
* Sarwar N, Rahman A, Rehman M, Hassan N. Thyroid Hormone Supplementation in Bipolar Disorder: A Literature Review. Cureus. 2022 Dec 7;14(12):e32297. doi: 10.7759/cureus.32297. PMID: 36620573; PMCID: PMC9819958.
* Kessing LV, Munkholm K, Rytgaard HC, Fosgerau C, Bech P. Impact of subclinical hypothyroidism on the course of bipolar disorder: A prospective cohort study. J Affect Disord. 2017 Jan 15;208:295-301. doi: 10.1016/j.jad.2016.09.049. Epub 2016 Oct 1. PMID: 27728867.
* Bauer M, Berghöfer A, Bschor T, Baumgartner A, Whybrow PC. Thyroid Hormone Treatment for Bipolar Depression: State of the Art and Future Directions. Bipolar Disord. 2011 Nov;13(7-8):615-30. doi: 10.1111/j.1399-5618.2011.00969.x. PMID: 22093551.
* Whybrow PC, Bauer M. The thyroid as a modulator of mood, cognition, and psychiatric illness. Dialogues Clin Neurosci. 2003;5(3):319-329. doi: 10.31887/DCNS.2003.5.3/pcwhybrow. PMID: 22033519; PMCID: PMC3181669.
Q.
Treatment Not Working? Why Bipolar Biobank Participation Is Your Scientific Next Step
A.
If your bipolar treatment isn’t working, joining a bipolar biobank could be a meaningful next step that complements your care, allowing you to contribute samples and health data that drive precision medicine to improve diagnosis, predict medication response, and increase awareness of new research opportunities. There are several factors to consider, including privacy safeguards, informed consent, confirming the right diagnosis, and coordinating with your psychiatrist before any changes. See complete guidance below to help you choose the safest next steps.
References:
* Zandi PP, et al. Building a Bipolar Disorder Biobank to Facilitate Precision Medicine in Psychiatry. J Clin Psychiatry. 2017 Aug;78(8):e966-e973. doi: 10.4088/JCP.16m11158. PMID: 28834015.
* O'Connell KS, et al. Precision Psychiatry for Bipolar Disorder: Integrating Neurobiology, Biomarkers, and Clinical Data. Int J Bipolar Disord. 2021 Nov 30;9(1):37. doi: 10.1186/s40345-021-00249-1. PMID: 34845507; PMCID: PMC8632669.
* Kittel-Schneider S, et al. Biobanks for mental health research: the challenge of improving patient participation and engagement. Eur Arch Psychiatry Clin Neurosci. 2019 Jun;269(4):451-460. doi: 10.1007/s00406-019-01009-1. Epub 2019 Apr 5. PMID: 30953046.
* Scott EM, et al. The Australian Bipolar Biobank: design, methods, and baseline clinical and demographic characteristics. Med J Aust. 2021 Jul;215(1):16-21. doi: 10.5694/mja2.51139. Epub 2021 Jul 5. PMID: 34224524.
* Correll CU, et al. Translational Biobanks for the Study of Mental Disorders: Current Status and Future Directions. Front Psychiatry. 2018 Aug 28;9:405. doi: 10.3389/fpsyt.2018.00405. PMID: 30202302; PMCID: PMC6120970.
Q.
Bipolar Symptoms? Why Your Brain Cycles & Medically Approved Next Steps
A.
Bipolar symptoms include distinct cycles of mania or hypomania and depression driven by biological brain factors and often triggered by sleep loss or stress, with signs ranging from reduced need for sleep, racing thoughts, and risky behavior to persistent sadness, concentration problems, and suicidal thoughts that require urgent care. There are several factors to consider; medically approved next steps include prompt evaluation by a clinician, mood stabilizers with cautious antidepressant use, evidence-based therapy, and consistent sleep and daily routines, with important specifics and emergency guidance provided below.
References:
* Chen, Y., Yu, Q., Zeng, Y., Li, M., Shi, Y., Han, H., ... & Zhang, Z. (2020). Neurobiology of bipolar disorder: A review of structural and functional brain imaging studies. *Journal of Affective Disorders*, *263*, 11-20.
* Grande, I., Aurich, S., & Bschor, T. (2022). Bipolar disorder: update on diagnosis and treatment. *Nervenarzt*, *93*(7), 651-660.
* Fountoulakis, K. N., Yatham, L. N., Grunze, H., & Vieta, E. (2023). The CINP guidelines on the definition and evidence-based treatment of bipolar disorder. *International Journal of Neuropsychopharmacology*, *26*(6), 395-430.
* Craddock, N., & Sklar, P. (2023). Bipolar disorder: genetic risk and gene discovery. *Molecular Psychiatry*, *28*(2), 522-535.
* Bora, E. (2023). The neurobiology of cognitive dysfunction in bipolar disorder. *Journal of Affective Disorders*, *322*, 19-33.
Q.
Manic Episode? Why Your Brain Won’t Stop & Medically Approved Next Steps
A.
A manic episode is a period of abnormally elevated or irritable mood with high energy, little need for sleep, racing thoughts, impaired judgment, and sometimes psychosis, driven by changes in brain chemistry and disrupted sleep cycles. There are several factors to consider, including common triggers, red-flag symptoms, and how it is diagnosed; see the complete details below. Medically approved next steps include urgent care if there is danger, hallucinations, or no sleep, prompt evaluation by a doctor, and evidence-based treatments such as mood stabilizers, antipsychotics, restoring sleep, possible hospitalization, plus long-term therapies and daily-rhythm strategies, with key safety tips and what to avoid listed below.
References:
* Gruber, J., Johnson, S. L., & Eisenlohr-Moul, T. A. (2014). The manic phase of bipolar disorder: a disorder of emotional and motivational dysregulation. *Clinical Psychology Review*, *34*(4), 302–312. pubmed.ncbi.nlm.nih.gov/24780655/
* Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., ... & Sharma, V. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients With Bipolar Disorder. *Bipolar Disorders*, *20*(Suppl 1), 1–16. pubmed.ncbi.nlm.nih.gov/29905018/
* Fountoulakis, K. N., Kontis, D., Gonda, X., Yatham, L. N., & Vieta, E. (2020). The Clinical Diagnosis and Treatment of Bipolar Disorder. *Psychiatric Clinics of North America*, *43*(1), 1–32. pubmed.ncbi.nlm.nih.gov/32008770/
* Egede, L. E., & Zheng, D. (2015). Psychosocial interventions for bipolar disorder: A systematic review and meta-analysis. *Journal of Affective Disorders*, *173*, 21–30. pubmed.ncbi.nlm.nih.gov/25460295/
* Wessa, M., & Thome, J. (2016). The manic brain: an update on brain imaging findings in acute mania. *Current Opinion in Psychiatry*, *29*(4), 213–218. pubmed.ncbi.nlm.nih.gov/27124376/
Q.
Bipolar Disorder Symptoms? Why Your Brain Is Spiraling & Medically-Approved Next Steps
A.
Bipolar disorder symptoms include manic or hypomanic highs and depressive lows, sometimes mixed, with little need for sleep, racing thoughts, impulsivity, and later crashes into sadness, fatigue, and hopelessness. There are several factors to consider, from brain chemistry and genetics to circadian disruption and triggers like stress, sleep loss, and substances. See below for medically approved next steps, including when to seek urgent care, how diagnosis is made, and effective treatments like mood stabilizers, atypical antipsychotics, therapy, and stabilizing daily routines, since key details such as medication cautions and safety red flags can change what you should do next.
References:
* Malhi GS, Outhred T, Morris G, Hamilton A, Boyce P. Bipolar disorder: a concise review of epidemiology, psychopathology, and current treatment paradigms. Curr Med Res Opin. 2017 Mar;33(3):525-535. doi: 10.1080/03007995.2016.1264222. Epub 2016 Dec 5. PMID: 27908151.
* Phillips ML, Kupfer DJ. Neurobiology of bipolar disorder: state-of-the-art and future directions. Mol Psychiatry. 2021 Jan;26(1):153-171. doi: 10.1038/s41380-020-00966-2. Epub 2020 Dec 7. PMID: 33288892; PMCID: PMC7778949.
* Stroup TS, Ketter TA, Schipper J. Bipolar disorder: A review of new treatment options and future directions. Psychopharmacology (Berl). 2023 May;240(5):1037-1052. doi: 10.1007/s00213-023-06334-9. Epub 2023 Mar 14. PMID: 36916960; PMCID: PMC10123547.
* Rosa AR, Grande I, Hidalgo-Mazzei JC, Fernandes M, Sanchez-Moreno J, Vieta E. The Pathophysiology of Bipolar Disorder: A Systematic Review. Harv Rev Psychiatry. 2019 Jul/Aug;27(4):213-228. doi: 10.1097/HRP.0000000000000216. PMID: 31219660.
* Berk M, Berk L. Bipolar disorder: An update on diagnosis and management. Aust J Gen Pract. 2021 Nov;50(11):814-818. doi: 10.31128/AJGP-04-21-5918. PMID: 34710186.
Q.
Is it Bipolar? Why Your Moods Cycle & Medically Approved Next Steps
A.
There are several factors to consider when moods swing beyond normal ups and downs, including episodes of mania or hypomania and depression that last days to weeks, often linked to sleep loss, stress, or substances and requiring a clinician’s evaluation. See below for key signs, look-alike conditions, urgent red flags, and medically approved next steps like tracking moods, using a symptom check, and seeing a clinician for evidence-based treatments such as mood stabilizers, therapy, and sleep-focused routines that make bipolar highly manageable.
References:
* Sachs, G. S., & Ghaemi, S. N. (2021). Distinguishing Bipolar Disorder From Major Depressive Disorder in Primary Care: A Narrative Review. *Journal of Clinical Psychiatry*, *82*(6), 21nr14227. doi:10.4088/JCP.21nr14227. PMID: 34680879.
* Wang, S., Xia, T., Wang, Y., Zhang, J., Hu, D., Yu, S., ... & Xu, Y. (2023). The neurobiology of bipolar disorder: An update on the neurotrophic, inflammatory, mitochondrial, and oxidative stress pathways. *Frontiers in Psychiatry*, *14*, 1109919. doi:10.3389/fpsyt.2023.1109919. PMID: 36768784.
* Fountoulakis, K. N., Kontis, D., Gonda, X., Yatham, L. N., Grunze, H., Young, A. H., ... & Koukopoulos, A. (2022). Clinical Practice Guidelines for Bipolar Disorder: An Overview of Available Literature. *Journal of Clinical Medicine*, *11*(2), 269. doi:10.3390/jcm11020269. PMID: 35087389.
* Popovic, D., & Vieta, E. (2023). Pharmacological Treatment of Bipolar Disorder: Current and Future Perspectives. *Neuropsychiatric Disease and Treatment*, *19*, 1515-1526. doi:10.2147/NDT.S387494. PMID: 37372332.
* Miklowitz, D. J., Efthimiou, O., & Scott, J. (2021). Psychological treatments for bipolar disorder: a systematic review and meta-analysis. *Lancet Psychiatry*, *8*(8), 711-722. doi:10.1016/S2215-0366(21)00030-9. PMID: 34874400.
Q.
Vraylar for Seniors: What Women 65+ Must Know About Side Effects
A.
For women 65 and older, Vraylar can help treat bipolar I disorder and schizophrenia, but age and gender make side effects more likely and slower to resolve. Key risks include restlessness or dizziness that increase fall risk, movement disorders such as EPS and tardive dyskinesia, cognitive changes, metabolic and blood pressure shifts, important drug interactions, and a boxed warning in dementia; because Vraylar has a long half-life, side effects can appear late. There are several factors to consider, including starting low with close monitoring, not stopping suddenly, and knowing when to seek urgent care for severe symptoms. See below for complete details that could meaningfully influence your next steps and discussion with your doctor.
References:
* Durgam S, et al. Cariprazine Safety and Tolerability in Elderly Patients With Schizophrenia: A Post Hoc Analysis of Pooled Phase II/III Studies. J Clin Psychiatry. 2022 Feb 22;83(2):21m14169. doi: 10.4088/JCP.21m14169. PMID: 35149363.
* Correll CU, et al. Cariprazine in the elderly: A review of its efficacy, safety and tolerability. Expert Opin Pharmacother. 2021 Nov;22(16):2205-2220. doi: 10.1080/14656566.2021.1990439. Epub 2021 Oct 18. PMID: 34653526.
* Durgam S, et al. Efficacy and Safety of Cariprazine in Elderly Patients With Schizophrenia: A Review. Adv Ther. 2021 Jul;38(7):3481-3498. doi: 10.1007/s12325-021-01740-1. Epub 2021 Apr 29. PMID: 33907080.
* Kiss B, et al. Clinical Pharmacology of Cariprazine: An Oral Atypical Antipsychotic. Clin Pharmacokinet. 2021 Apr;60(4):461-477. doi: 10.1007/s40262-020-00971-8. Epub 2021 Feb 23. PMID: 33748981.
* Citrome L. Cariprazine: A Comprehensive Review of Clinical Efficacy, Safety, and Tolerability for the Treatment of Schizophrenia and Bipolar I Disorder. Drugs. 2023 Sep;83(13):1219-1234. doi: 10.1007/s40265-023-00947-6. Epub 2023 Aug 18. PMID: 37706173.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1Smith DJ, Whitham EA, Ghaemi SN. Bipolar disorder. Handb Clin Neurol. 2012;106:251-63. doi: 10.1016/B978-0-444-52002-9.00015-2. PMID: 22608626.
https://www.sciencedirect.com/science/article/abs/pii/B9780444520029000152?via%3DihubSolé B, Jiménez E, Torrent C, Reinares M, Bonnin CDM, Torres I, Varo C, Grande I, Valls E, Salagre E, Sanchez-Moreno J, Martinez-Aran A, Carvalho AF, Vieta E. Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies. Int J Neuropsychopharmacol. 2017 Aug 1;20(8):670-680. doi: 10.1093/ijnp/pyx032. PMID: 28498954; PMCID: PMC5570032.
https://academic.oup.com/ijnp/article/20/8/670/3813906Tondo L, Vázquez GH, Baldessarini RJ. Depression and Mania in Bipolar Disorder. Curr Neuropharmacol. 2017 Apr;15(3):353-358. doi: 10.2174/1570159X14666160606210811. PMID: 28503106; PMCID: PMC5405618.
http://www.eurekaselect.com/article/76306Zimmerman M, Morgan TA. The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neurosci. 2013 Jun;15(2):155-69. doi: 10.31887/DCNS.2013.15.2/mzimmerman. PMID: 24174890; PMCID: PMC3811087.
https://www.tandfonline.com/doi/full/10.31887/DCNS.2013.15.2/mzimmermanFreund N, Juckel G. Bipolar Disorder: Its Etiology and How to Model in Rodents. Methods Mol Biol. 2019;2011:61-77. doi: 10.1007/978-1-4939-9554-7_4. PMID: 31273693.
https://link.springer.com/protocol/10.1007/978-1-4939-9554-7_4